New York State Common Retirement Fund Praxis Precision Medicines, Inc. Transaction History

New York State Common Retirement Fund

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$0.83 - $1.18 $4,569 - $6,495	-5,505 Reduced 94.39%	327 $0
Q1 2023 May 02, 2023	SELL	$0.8 - $4.98 $16,400 - $102,090	-20,500 Reduced 77.85%	5,832 $5,000
Q4 2022 Jan 30, 2023	SELL	$1.88 - $36.45 $137 - $2,660	-73 Reduced 0.28%	26,332 $63,000
Q3 2022 Nov 08, 2022	BUY	$2.5 - $37.95 $435 - $6,603	174 Added 0.66%	26,405 $60,000
Q2 2022 Aug 04, 2022	BUY	$1.75 - $11.34 $7,910 - $51,256	4,520 Added 20.82%	26,231 $64,000
Q1 2022 May 05, 2022	BUY	$10.21 - $20.29 $255 - $507	25 Added 0.12%	21,711 $222,000
Q4 2021 Feb 02, 2022	BUY	$16.76 - $22.99 $91,107 - $124,973	5,436 Added 33.45%	21,686 $427,000
Q3 2021 Nov 02, 2021	SELL	$13.15 - $22.56 $62,317 - $106,911	-4,739 Reduced 22.58%	16,250 $300,000
Q2 2021 Aug 02, 2021	BUY	$18.28 - $33.05 $191,738 - $346,661	10,489 Added 99.9%	20,989 $384,000
Q1 2021 May 11, 2021	BUY	$29.34 - $60.2 $55,746 - $114,380	1,900 Added 22.09%	10,500 $344,000
Q4 2020 Feb 08, 2021	BUY	$27.25 - $55.82 $234,350 - $480,052	8,600 New	8,600 $473,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.